Similar Items: Optimising linezolid use for drug-resistant tuberculosis: pharmacokinetics, toxicity, and resistance
- Extensively drug resistant tuberculosis in South Africa
- The epidemiology and management of drug-resistant tuberculosis in childhood
- Antimicrobial resistance mechanisms of linezolid resistant staphylococci and enterococci collected in Gauteng, South Africa
- Efficacy and safety of novel and repurposed drugs for the treatment of drug-resistant tuberculosis
- The evolution of the Mycobacterium tuberculosis proteome in response to the development of drug resistance
- Resistance to new tuberculosis drugs
Author: Meintjes, Graeme
- The immunomodulatory role of prednisone in patients with HIV-associated tuberculosis and assessment of its impact on lung function outcome
- Investigating the molecular pathogenesis of tuberculosis-associated immune reconstitution inflammatory syndrome
- Optimising linezolid use for drug-resistant tuberculosis: pharmacokinetics, toxicity, and resistance
- Characterization of and risk factors for HIV-1 resistance mutations following first line antiretroviral failure in the southern African private sector
- Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug-resistant tuberculosis: A retrospective cohort study
- Diagnosis, treatment and immunopathogenesis of the HIV-associated tuberculosis immune reconstitution inflammatory syndrome